eCommons@AKU

Title

BRAF mutations increase response to MEK inhibition

Authors

Khabir Ahmed, Aga Khan UniversityFollow

Document Type

Article

Department

Ophthalmology

Abstract

Tumours with BRAF mutations, irrespective of site of origin, are sensitive to mitogen-activated protein kinase kinase (MEK) inhibitors, say researchers in Nature

Publication ( Name of Journal)

Lancet Oncology

Recommended Citation

Ahmed, K. (2005). BRAF mutations increase response to MEK inhibition. Lancet Oncology, 6(12), 926.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_surg/418